[{"id":"e8106815-807d-440d-af1d-1076b6e5a743","acronym":"","url":"https://clinicaltrials.gov/study/NCT05318443","created_at":"2022-04-08T21:52:56.841Z","updated_at":"2024-07-02T16:35:25.142Z","phase":"Phase 3","brief_title":"A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer","source_id_and_acronym":"NCT05318443","lead_sponsor":"Shanghai Institute Of Biological Products","biomarkers":" EGFR • ALK • ROS1","pipe":" | ","alterations":" ALK positive • ROS1 positive","tags":["EGFR • ALK • ROS1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ALK positive • ROS1 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Avastin (bevacizumab) • carboplatin • paclitaxel • SIBP-04 (bevacizumab biosimilar)"],"overall_status":"Completed","enrollment":" Enrollment 512","initiation":"Initiation: 04/17/2020","start_date":" 04/17/2020","primary_txt":" Primary completion: 12/26/2022","primary_completion_date":" 12/26/2022","study_txt":" Completion: 01/12/2023","study_completion_date":" 01/12/2023","last_update_posted":"2023-12-27"}]